Quadrivalent HPV [Type 6, 11, 16 and 18] L1 Virus-Like Particle Vaccine

DRUG2 trials

Sponsors

Kenya Medical Research Institute

Conditions

HIV-1-infectionHPV InfectionHPV VaccineHPV-Related Carcinoma

Unknown Phase

Antibody Response to Prophylactic QHPV Vaccine at 48 Months Among HIV-infected Girls and Boys

CompletedNCT04711265

Kenya Medical Research InstituteHIV-1-infection, HPV Infection, HPV Vaccine

Start: 2015-09-30End: 2019-01-31Updated: 2021-01-15

Effectiveness and B-memory Cell Response to QHPV Vaccine 9-years Post-vaccination Among HIV-infected Boys and Girls

Kenya Medical Research InstituteHPV-Related Carcinoma

Start: 2021-08-31End: 2022-12-31Target: 135Updated: 2021-06-10